Medicare Enrolled
Dr. Lalit Aneja, MD
Medical Oncology · North Venice, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aneja from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aneja? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aneja
Dr. Lalit Aneja is a medical oncology in North Venice, FL, with 13 years in practice. Based on federal Medicare data, Dr. Aneja performed 265,788 Medicare services across 6,134 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aneja received a total of $16,046 from 77 pharmaceutical and/or device companies across 745 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aneja is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice▲ Top 7% volume in FL$ $16,046 industry payments
Medicare Practice Summary
Medicare Utilization ↗265,788
Medicare services
Top 7% in FL for medical oncology
6,134
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~20,445 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 128,010 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 17,290 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 13,600 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 13,320 | $18 | $51 |
| Oxaliplatin chemotherapy injection | 11,700 | $0 | $12 |
| Paclitaxel chemotherapy injection | 11,474 | $0 | $2 |
| Azacitidine chemotherapy injection | 10,298 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia | 10,000 | $6 | $23 |
| Filgrastim injection (Zarxio) for white blood cells | 7,620 | $0 | $2 |
| Immune globulin infusion (Gammagard) | 6,230 | $36 | $108 |
| Iron sucrose injection (Venofer) | 5,700 | $0 | $5 |
| Complete blood count (CBC) with differential | 3,569 | $8 | $29 |
| Dexamethasone injection (steroid) | 3,540 | $0 | $3 |
| Blood draw (venipuncture) | 3,455 | $8 | $9 |
| Injection, eflapegrastim-xnst, 0.1 mg | 3,300 | $26 | $116 |
| Office visit, established patient (30-39 min) | 2,222 | $95 | $339 |
| Iron infusion (Monoferric) | 2,100 | $16 | $57 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,720 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,417 | $10 | $69 |
| Injection, leucovorin calcium, per 50 mg | 1,005 | $3 | $12 |
| Anti-nausea injection (ondansetron/Zofran) | 980 | $0 | $9 |
| Injection of additional new drug or substance into vein | 959 | $12 | $61 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 723 | $1 | $6 |
| Injection, fluorouracil, 500 mg | 628 | $2 | $7 |
| Administration of chemotherapy into vein, 1 hour or less | 605 | $96 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 384 | $47 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 353 | $15 | $56 |
| Administration of chemotherapy into vein, each additional hour | 248 | $21 | $79 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 246 | $21 | $84 |
| Injection, diphenhydramine hcl, up to 50 mg | 244 | $1 | $3 |
| Injection of drug or substance into vein | 229 | $27 | $156 |
| Injection, carboplatin, 50 mg | 219 | $2 | $41 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 214 | $16 | $59 |
| Office visit, established patient (20-29 min) | 214 | $62 | $239 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 156 | $3 | $11 |
| Administration of additional new drug or substance into vein, 1 hour or less | 148 | $49 | $178 |
| Infusion into a vein for hydration, each additional hour | 142 | $10 | $42 |
| Injection, zoledronic acid, 1 mg | 136 | $7 | $69 |
| New patient office visit (45-59 min) | 126 | $128 | $453 |
| Red blood count automated, with additional calculations | 124 | $5 | $20 |
| Infusion, normal saline solution , 1000 cc | 113 | $2 | $7 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 110 | $132 | $562 |
| Prothrombin time test (blood clotting) | 107 | $4 | $15 |
| Office visit, established patient, complex (40-54 min) | 88 | $133 | $474 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 85 | $53 | $206 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 82 | $25 | $89 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 71 | $128 | $637 |
| Automated urinalysis | 68 | $2 | $8 |
| Infusion into a vein for hydration, 31-60 minutes | 64 | $24 | $156 |
| Administration of additional new drug or substance into vein using push technique | 56 | $42 | $170 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 55 | $15 | $56 |
| Drawing of blood for a medical problem | 55 | $68 | $277 |
| New patient office visit, complex (60-74 min) | 40 | $167 | $585 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 39 | $1 | $7 |
| Hospital follow-up visit, moderate complexity | 30 | $61 | $197 |
| Hospital follow-up visit, high complexity | 26 | $94 | $285 |
| Initial hospital admission, high complexity | 25 | $137 | $556 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 15 | $128 | $467 |
| New patient office visit (30-44 min) | 11 | $73 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
51.8% high complexity
44.1% medium
4.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,046
Total received (2018-2024)
Avg $2,292/year across 7 years
Top 32% in FL for medical oncology
77
Companies
745
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,359 (83.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,425 (8.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,262 (7.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,378
2023$2,966
2022$2,427
2021$3,123
2020$654
2019$1,653
2018$1,845
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,850
E.R. Squibb & Sons, L.L.C.
$1,282
Epizyme, Inc.,
$1,265
Novartis Pharmaceuticals Corporation
$1,012
PFIZER INC.
$738
Janssen Biotech, Inc.
$670
Genentech USA, Inc.
$662
Merck Sharp & Dohme LLC
$594
Celgene Corporation
$553
Lilly USA, LLC
$546
Daiichi Sankyo Inc.
$445
Merck Sharp & Dohme Corporation
$425
Amgen Inc.
$414
Incyte Corporation
$333
Gilead Sciences, Inc.
$287
Astellas Pharma US Inc
$283
GENZYME CORPORATION
$259
Seagen Inc.
$251
Takeda Pharmaceuticals U.S.A., Inc.
$250
BeiGene USA, Inc.
$250
Exelixis Inc.
$237
GlaxoSmithKline, LLC.
$216
Regeneron Healthcare Solutions, Inc.
$201
Kite Pharma, Inc.
$188
Eisai Inc.
$184
Bayer HealthCare Pharmaceuticals Inc.
$155
Dendreon Pharmaceuticals LLC
$130
ARRAY BIOPHARMA INC
$122
SOBI, INC
$121
JAZZ PHARMACEUTICALS INC.
$116
Kyowa Kirin, Inc.
$105
EMD Serono, Inc.
$97
Alexion Pharmaceuticals, Inc.
$96
Janssen Pharmaceuticals, Inc
$91
ABBVIE INC.
$87
Dova Pharmaceuticals
$85
Puma Biotechnology, Inc.
$82
Janssen Scientific Affairs, LLC
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Bayer Healthcare Pharmaceuticals Inc.
$67
Sumitomo Pharma America, Inc.
$66
ARGENX US, INC.
$62
ADC Therapeutics America, Inc.
$54
Genmab U.S., Inc.
$54
Agios Pharmaceuticals, Inc.
$50
Mirati Therapeutics, Inc.
$48
Deciphera Pharmaceuticals Inc.
$45
Pharmacyclics LLC, An AbbVie Company
$45
Karyopharm Therapeutics Inc.
$43
PUMA BIOTECHNOLOGY, INC.
$42
Rigel Pharmaceuticals, Inc.
$41
EISAI INC.
$40
PharmaEssentia USA Corporation
$38
Epizyme, Inc.
$37
Acrotech Biopharma LLC
$32
TAIHO ONCOLOGY, INC.
$30
ImmunoGen, Inc.
$28
Myovant Sciences Inc.
$28
Lexicon Pharmaceuticals, Inc.
$26
Clovis Oncology, Inc.
$25
Foundation Medicine, Inc.
$25
Heron Therapeutics, Inc.
$25
MorphoSys, US Inc.
$22
Sysmex Inostics Inc
$22
TOLMAR Pharmaceuticals, Inc.
$22
G1 Therapeutics, Inc.
$21
Aveo Pharmaceuticals, Inc.
$20
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
INSYS Therapeutics Inc
$19
GE HealthCare
$19
CTI BioPharma Corp.
$15
Acrotech Biopharma Inc.
$15
Array BioPharma Inc.
$14
Jazz Pharmaceuticals Inc.
$14
AbbVie, Inc.
$14
Taiho Oncology, Inc.
$13
Spectrum Pharmaceuticals Inc.
$12
Top 3 companies account for 27.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Elahere · Enhertu · Epkinly · Erleada · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · HYQVIA · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SUBSYS · SUTENT · Stivarga · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYVGART · VYVGART HYTRULO · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYNYZ · ZYTIGA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
11
Per 100K population
2.4
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Aneja is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Aneja experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Aneja performed 128,010 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aneja receive payments from pharmaceutical companies?
Yes. Dr. Aneja received a total of $16,046 from 77 companies across 745 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aneja's costs compare to other medical oncologys in North Venice?
Dr. Aneja's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aneja) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in North Venice
Browse medical oncologys in North Venice ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Epizyme, Inc., Payments to Doctors
See all physicians who received payments from Epizyme, Inc.,.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology